Warberg Asset Management LLC - CLARUS THERAPEUTICS HLDNGS I ownership

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 18 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Warberg Asset Management LLC ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q1 2022$20,000
+122.2%
130,000
+300.0%
0.00%
-100.0%
Q4 2021$9,000
-91.4%
32,502
-76.8%
0.00%
-88.2%
Q3 2021$105,000139,8400.02%
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q1 2022
NameSharesValueWeighting ↓
Integrity Capital Management (HK) Ltd 69,724$20,0000.06%
Privium Fund Management B.V. 163,030$42,0000.01%
LMR Partners LLP 229,750$558,0000.01%
CVI Holdings, LLC 264,407$77,0000.01%
Yakira Capital Management, Inc. 127,497$37,0000.01%
Telemetry Investments, L.L.C. 15,156$4,0000.01%
Bulldog Investors, LLP 43,258$12,0000.00%
Context Capital Management, LLC 87,175$25,0000.00%
Warberg Asset Management LLC 32,502$9,0000.00%
RIVERNORTH CAPITAL MANAGEMENT, LLC 66,986$19,0000.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders